相关实验视频

Updated: Dec 20, 2025

High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence

High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence

Published on: February 23, 2021

在多种耐药性Mycobacterium结核病中保存假定液态-液态相分离蛋白:宿主-病原体相互作用中的作用?

Jasdeep Singh^1,2, Prashant Pradhan³, Arti Kataria⁴

¹Department of Chemistry and Biochemistry, University of Denver, Denver, Colorado 80210, United States.

ACS infectious diseases

|April 4, 2025

概括

致病性细菌,如Mycobacterium物种,比非致病性细菌表现出更多能够进行液态分离 (LLPS) 的蛋白质. 这些蛋白质可能是了解结核病毒性和开发新治疗方法的关键.

科学领域:

微生物学微生物学
分子生物学分子生物学
生物化学生物化学

背景情况:

液-液相分离 (LLPS) 驱动生物分子凝聚物形成,对细胞组织至关重要.
病原细菌拥有独特的蛋白质家族,如Mycobacterium物种中的PE-PPE和PE-PGRS,在毒性方面可能发挥作用.

研究的目的:

调查LLPS相关蛋白在致病性与非致病性Mycobacterium物种中的流行率.
探索这些LLPS蛋白在Mycobacterium结核病 (M.tb) 病原和耐药性中的作用.

主要方法:

在不同Mycobacterium物种中对参与LLPS的蛋白质家族进行比较分析.
在M.tb耐药数据库中识别的LLPS蛋白质的映射与世卫组织耐药性相关突变目录对比.

主要成果:

致病性Mycobacterium物种表现出具有LLPS潜力的蛋白质的比例较高,特别是PE-PPE和PE-PGRS家族.
在多药耐药的M.tb分离物中,LLPS蛋白显示出高序列保存,这表明在毒性和宿主相互作用中发挥了作用.

结论:

LLPS蛋白质,特别是PE-PPE和PE-PGRS,涉及到M.tb的发病和毒性.
了解蛋白质相分离为对抗M.tb感染和抗药性提供了新的策略.

关键词:

生物分子凝聚物是生物分子的凝聚物.功能性基因组学是一种功能性基因组学.宿主-病原体相互作用液体 - 液相分离器在M.结核病.

更多相关视频

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

Published on: February 17, 2014

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...